General News

Liolis Gateway September 2018 Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

Investor Updates

Liolis Gateway September 2018 Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

Appointment of Executive Officer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported)   September 4, 2018   REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter)   New … Continued

CEO, Andy Sealfon, discusses RMS company updates and other exciting news

Join Andy Sealfon as he discusses recent happenings at RMS on the Princeton Research Radio Show. Andy talks about various international updates including the International Distributor meeting that took place in Berlin in early June and shares some great feedback from the ongoing clinical trials in Russia with a pharmaceutical company.  He also discusses RMS’ … Continued